中国癌症杂志 ›› 2022, Vol. 32 ›› Issue (7): 606-613.doi: 10.19401/j.cnki.1007-3639.2022.07.004

• 论著 • 上一篇    下一篇

程序性死亡[蛋白]-1抑制剂诱导小鼠心肌炎模型的建立

陈怡帆1,2,3()(), 程蕾蕾2,3,4()(), 沈毅辉2,3,4, 张卉2,3,4, 汪雪君2,3,4, 许宇辰1,2,3, 葛均波1,2,3   

  1. 1.复旦大学附属中山医院心内科,上海 200032
    2.上海市心血管病研究所,上海 200032
    3.国家放射与治疗临床医学研究中心,上海 200032
    4.复旦大学附属中山医院心脏超声诊断科,上海 200032
  • 收稿日期:2022-03-08 出版日期:2022-07-30 发布日期:2022-08-09
  • 通信作者: 程蕾蕾 E-mail:21111210020@m.fudan.edu.cn;cheng.leilei@zs-hospital.sh.cn
  • 作者简介:陈怡帆(ORCID: 0000-0001-9161-8268),博士,E-mail: 21111210020@m.fudan.edu.cn
  • 基金资助:
    国家自然科学基金(82170359);上海介入治疗工程技术研究中心(19DZ2250300);国家放射与治疗临床医学研究中心(19MC1910300)

Establishment of a mouse myocarditis model induced by programmed death-1 inhibitor

CHEN Yifan1,2,3()(), CHENG Leilei2,3,4()(), SHEN Yihui2,3,4, ZHANG Hui2,3,4, WANG Xuejun2,3,4, XU Yuchen1,2,3, GE Junbo1,2,3   

  1. 1. Department of Cardiology, Zhongshan Hospital, Fudan University, Shanghai 200032, China
    2. Shanghai Institute of Cardiovascular Diseases, Shanghai 200032, China
    3. National Clinical Research Center for Interventional Medicine, Shanghai 200032, China
    4. Department of Echocardiography, Zhongshan Hospital, Fudan University, Shanghai 200032, China
  • Received:2022-03-08 Published:2022-07-30 Online:2022-08-09
  • Contact: CHENG Leilei E-mail:21111210020@m.fudan.edu.cn;cheng.leilei@zs-hospital.sh.cn

摘要:

背景与目的: 程序性死亡[蛋白]-1(programmed death-1,PD-1)抑制剂诱发的心肌炎亟待通过动物模型探究治疗靶点。本研究旨在探索此类自身免疫性心肌炎小鼠模型的最佳造模方法。方法: 选取6周龄健康雄性BALB/c小鼠30只,分别编号并随机分为对照组(control组)、自身免疫性心肌炎组(TnⅠ组)和免疫检查点抑制剂(immune checkpoint inhibitor,ICI)相关心肌炎组(TnⅠ+anti-PD-1组),每组10只。除control组外,分别于第1、7天给小鼠皮下注射0.1 mL含有0.25 mg小鼠心肌TnⅠ肽段的完全弗氏佐剂。TnⅠ+anti-PD-1组自第7天起,每次5 mg/kg腹腔注射PD-1抑制剂,每2 d给药1次,共5次,累积剂量25 mg/kg。观察小鼠的一般状态、死亡率、心脏指数、超声心动图、心肌病理学改变、血清肌酸激酶(creatine kinase,CK)及CK同工酶(CK isoenzyme,CK-MB)水平。结果: 与control组相比,造模第21、56天,TnⅠ和TnⅠ+anti-PD-1组体重均显著下降(P<0.05,P<0.01),两组间体重有显著差异(P<0.05),进食量均显著下降(P<0.05,P <0.01)。两组的死亡率在第21天分别为0%和10%,在第56天分别为10%和20%。第56天,TnⅠ组心脏指数未显著增加(P>0.05),TnⅠ+anti-PD-1组显著增加(P<0.05),且左心室射血分数(ejection fraction,EF)显著下降(P<0.001)。急性心肌炎期,TnⅠ组心外膜下见少量炎症细胞浸润,TnⅠ+anti-PD-1组心外膜下见大量炎症细胞浸润,心肌细胞坏死。扩张型心肌病期,TnⅠ组炎症细胞浸润减少,心肌细胞轻度边界不清、空泡化,TnⅠ+anti-PD-1组细胞坏死、空泡化、核异形更显著。第56天,TnⅠ+anti-PD-1组血清CK、CK-MB显著升高(P<0.001),且较TnⅠ组升高更明显(CK:P <0.01;CK-MB:P<0.05)。结论: 建立了PD-1抑制剂诱导的、低死亡率的小鼠心肌炎模型,以心肌急慢性自身免疫炎性改变、左心室EF下降、心肌酶谱升高为突出特征。设计合成了特殊的小鼠心肌TnⅠ肽段,强化了PD-1抑制剂的造模效果。

关键词: 程序性死亡[蛋白]-1抑制剂, 免疫检查点抑制剂相关心肌炎, 小鼠, 模型

Abstract:

Background and purpose: Myocarditis induced by programmed death-1 (PD-1) inhibitors is in urgent need of animal models to explore therapeutic targets. The study aimed to figure out the best modeling method of this typical autoimmune myocarditis in mice. Methods: Thirty 6-week-old healthy male BALB/c mice were numbered and randomly divided into control group, autoimmune myocarditis group (TnⅠgroup) and immune checkpoint inhibitor (ICI)-related myocarditis group (TnⅠ+anti-PD-1 group), 10 in each group. Except for the control group, mice were subcutaneously injected with 0.1 mL complete Freund’s adjuvant containing 0.25 mg of mouse cardiac TnⅠ peptide on day 1 and day 7, respectively. From day 7, TnⅠ+anti-PD-1 group received intraperitoneal injection of PD-1 inhibitor at 5 mg/kg each time, once every 2 d, for a total of 5 times with a cumulative dose of 25 mg/kg. The general state, mortality, cardiac index, echocardiography, myocardial pathology and the levels of creatine kinase (CK) and CK isoenzyme (CK-MB) in serum were observed. Results: Compared with control group, the mass of mice in both TnⅠ and TnⅠ+anti-PD-1 groups decreased significantly on day 21 and day 56 (P<0.05, P<0.01), and there was a significant difference between these 2 groups (P<0.05). Both had significantly decreased food intake (compared with control group, P<0.05, P<0.01). The mortality rates were 0% and 10% on day 21, and 10% and 20% on day 56 in TnⅠ and TnⅠ+anti-PD-1 groups, respectively. On day 56, no significant increase in cardiac index could be observed in TnⅠ group (P>0.05), while a significant rise of cardiac index (P<0.05) with a decrease in left ventricular ejection fraction (EF) (P<0.001) were detected in TnⅠ+anti-PD-1 group. During the acute myocarditis stage, mild subepicardial inflammatory infiltration was found in TnⅠ group; Severe subepicardial inflammatory infiltration and myocardial cell necrosis were seen in TnⅠ+anti-PD-1 group. During the dilated cardiomyopathy stage, the infiltrated inflammatory cells in TnⅠ group decreased, mild boundaries unclear and cytoplasm vacuolization could be observed; TnⅠ+anti-PD-1 group also had decreased inflammatory infiltration while underwent more severe cell necrosis and vacuolization with nuclear atypia. On day 56, serum CK and CK-MB in TnⅠ+anti-PD-1 group rose significantly (P<0.001), which was more obvious compared with TnⅠ group (CK: P<0.01; CK-MB: P<0.05). Conclusion: A PD-1 inhibitor-induced myocarditis model with low mortality was established in mice, characterized by acute and chronic autoimmune myocardial inflammation, decreased ejection fraction and increased myocardial enzyme spectrum. A mouse cardiac TnⅠ peptide fragment was particularly designed and synthesized for modeling.

Key words: Programmed death-1 inhibitor, Immune checkpoint inhibitor-associated myocarditis, Mouse, Model

中图分类号: